Newborn Screening Market Size by End-user & Region, Key Players: DiaDx, Roche, Myriad Genetics, Qiagen, Exosome Sciences, Inc., Inivata Limited.

Newborn Screening Market is expected to reach USD 2,258.12 million by 2025 from USD 1,008.64 million in 2017, at a CAGR of 10.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Get Free Sample Report@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-newborn-screening-market

The major factors contributing to the growth of the market includes factors such as rising prevalence of new born screening, growth in neonatal diseases, increased government funding and technological advancements in screening. On the other hand, high cost of automated devices and stringent regulatory policies.

Major Market Competitors:

• PerkinElmer Inc.,
• Trivitron Healthcare,
• Interacoustics A/S ,
• Bio-Rad Laboratories, Inc.,
• Natus Medical Incorporated,
• Masimo,
• Medtronic,
• Intelligent Hearing Systems,
• Otodynamics Ltd,
• Vivosonic Inc.,
• ZenTech S.A.,
• AB Sciex, Welch Allyn,
• Baebies, Inc.
• Among Others

Questions? We’ll Put You on the Right Path Request Analyst Call @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-newborn-screening-market

Key Drivers: Newborn Screening Market

Some of the major factors driving the market for global newborn screening market are raising prevalence of new born screening, growth in neonatal diseases, increased government funding and technological advancements in screening.

On the other hand, high cost of automated devices and stringent regulatory policies are hampering the growth of the market.

Key Points:

• The dried blood spot segment is dominating the global new born screening market.

• The instruments segment is expected to grow with the highest CAGR of 8.0% in the forecast period 2018 to 2025.

Market Segmentation: Newborn Screening Market

• The global newborn screening market is segmented on the basis of test types into dried blood spot (DBS) test, critical congenital heart diseases (CCHD) test and hearing screen test. In 2018, dried blood spot segment is projected to dominate the market with a share of around 44.0%.

• The global newborn screening market is segmented on the basis of product type into instruments and reagents & assay kits. In 2018, the instruments segment is estimated to dominate market with a share of around 68.0%. The instruments are further sub-segmented into newborn disorder screening, newborn hearing screening, and pulse oximeter.

• The global newborn screening market is segmented on the basis of technologies into tandem mass spectrometry, hearing screen, pulse oximetry screening, immunoassays and enzymatic assays, electrophoresis and DNA-based assays. In 2018, tandem mass spectrometry segment is likely to dominate the market and it is expected to grow at the highest CAGR in the forecast period.

• The global newborn screening market is segmented on the basis of disease type into phenylketonuria, cystic fibrosis, sickle cell disease, newborn hearing loss, critical congenital heart diseases, maple syrup urine disease and others. In 2018, critical congenital heart diseases segment will dominate the market and is projected to reach 1,492.98 million by 2025.

• The global newborn screening market is divided on the basis of end user into hospitals, pediatric clinics, and clinics. In 2018, hospitals segment is expected to dominate market with a share of around 70% and is estimated to grow at the highest CAGR of 10.9%.

• Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa.

Repot Brief Focus On:

Newborn Screening Market By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases Test), Product Type (Instruments, Reagents & Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays And Enzymatic Assays, Electrophoresis, DNA-Based Assays), Diseases Type (Phenylketonuria, Cystic Fibrosis, Sickle Cell Disease, Newborn Hearing Loss, Critical Congenital Heart Diseases, Maple Syrup Urine Disease), End User (Hospital, Pediatric Clinics, Clinics), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)- Industry Trends and Forecast to 2025

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Customization With Discount Available On This Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-newborn-screening-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavorsto provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com

This release was published on openPR.